In true MiFID style

The European Commission (EC) has published the first in a series of highly anticipated delegated acts, defining some of the crucial details for MiFID II. Most relevant in yesterday’s document is the unbundling of research and execution fees, where the EC has largely followed the advice given by ESMA back in December 2014. In true MiFID II style, a new acronym is introduced, each side of the argument is given some concessions and the man on the street will doubtless remain as baffled as ever by how entangled the rules governing financial markets have become. It’s like DVC (double volume cap) all over again!

But let’s start at the beginning. Firstly, MiFID II will go ahead with the introduction of the RPA construct (Research Payments Account). Secondly, Article 13(1) clearly states that research is considered an inducement (demand by one side) unless it is paid directly from the buy-side or through an RPA. Interestingly, research is a pretty loaded word in the context of MiFID II and a discussion on that could take up a whole other blog. Thirdly, Article 13(3) seems to imply that CSAs can remain in use (demand by the other side) so long as they meet the RPA requirements.

For any buy-side firm that just doesn’t want to deal with all that added complexity, outsourcing probably looks pretty appealing right now. And as luck would have it, the legislators were thoughtful enough to provide rules around outsourcing of RPAs under Article 13(7). I just wonder how firms will pay for that.

Leave A Comment

Copyright © 2019 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.